Effects of 3,4-methylenedioxy-methamphetamine (MDMA) on anxiety in mice tested in the light-dark box

E Maldonado1, J F Navarro

  • 1Area de Psicobiología, Facultad de Psicología, Universidad de Málaga, Spain.

Insights

Acute administration of 3,4-methylenedioxymethamphetamine (MDMA) showed anxiogenic-like activity in mice. Higher doses reduced exploratory behavior without impacting general motility, suggesting complex anxiety responses.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Behavioral Science

Background:

  • 3,4-methylenedioxymethamphetamine (MDMA), commonly known as "ecstasy", is a psychoactive drug with complex effects.
  • Understanding MDMA's impact on anxiety is crucial for assessing its potential risks and therapeutic applications.

Purpose of the Study:

  • To investigate the acute effects of MDMA on anxiety-like behavior in a mouse model.
  • To determine the dose-dependent behavioral responses to MDMA administration.

Main Methods:

  • Male OF.1 mice were administered MDMA (1, 8, 15 mg/kg) or saline intraperitoneally.
  • Behavioral parameters including exploratory rearings, transitions, time spent in compartments, and locomotor activity were recorded in the light/dark test 30 minutes post-injection.

Main Results:

  • MDMA at 8 and 15 mg/kg significantly reduced exploratory rearings and transitions compared to saline controls.
  • Locomotor activity and time spent in light/dark compartments were not significantly altered by MDMA.
  • The observed reduction in exploration, without changes in motility, suggests an anxiogenic-like effect.

Conclusions:

  • Acute MDMA administration exhibits anxiogenic-like properties in mice, primarily through reducing exploratory behaviors.
  • The study suggests that anxiety models incorporating social interaction may offer greater sensitivity to MDMA's effects.

Related Concept Videos